You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

NIFEDIPINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for nifedipine and what is the scope of freedom to operate?

Nifedipine is the generic ingredient in six branded drugs marketed by Bayer Pharms, Acella, Actavis Elizabeth, Chase Labs Nj, Heritage Pharma, Leading, Teva, Pfizer, Norwich, Watson Labs, Watson Labs Teva, Alembic, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Usa, Elite Pharm Solution, Martec Usa Llc, Mylan, Novast Labs, Osmotica Pharm Us, Par Pharm, Rising, Spil, Twi Pharms, Valeant Pharms North, Vitruvias, and Zydus Pharms, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for nifedipine. Thirty-seven suppliers are listed for this compound.

Drug Prices for NIFEDIPINE

See drug prices for NIFEDIPINE

Drug Sales Revenue Trends for NIFEDIPINE

See drug sales revenues for NIFEDIPINE

Recent Clinical Trials for NIFEDIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Queen Mary University of LondonN/A
Medical College of WisconsinPhase 3
Shaheed Zulfiqar Ali Bhutto Medical UniversityN/A

See all NIFEDIPINE clinical trials

Pharmacology for NIFEDIPINE
Medical Subject Heading (MeSH) Categories for NIFEDIPINE

US Patents and Regulatory Information for NIFEDIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Usa NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 090649-002 Jun 21, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 213361-001 Jul 19, 2021 AB1 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rising NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 201071-003 Dec 3, 2010 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 213361-003 Jul 19, 2021 AB1 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alembic NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 216896-001 Nov 18, 2022 AB2 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus Pharms NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 210012-003 Dec 19, 2017 AB2 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NIFEDIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PROCARDIA XL nifedipine TABLET, EXTENDED RELEASE;ORAL 019684-001 Sep 6, 1989 ⤷  Try a Trial ⤷  Try a Trial
Pfizer PROCARDIA XL nifedipine TABLET, EXTENDED RELEASE;ORAL 019684-002 Sep 6, 1989 ⤷  Try a Trial ⤷  Try a Trial
Norwich ADALAT CC nifedipine TABLET, EXTENDED RELEASE;ORAL 020198-002 Apr 21, 1993 ⤷  Try a Trial ⤷  Try a Trial
Bayer Pharms ADALAT nifedipine CAPSULE;ORAL 019478-001 Nov 27, 1985 ⤷  Try a Trial ⤷  Try a Trial
Norwich ADALAT CC nifedipine TABLET, EXTENDED RELEASE;ORAL 020198-001 Apr 21, 1993 ⤷  Try a Trial ⤷  Try a Trial
Pfizer PROCARDIA XL nifedipine TABLET, EXTENDED RELEASE;ORAL 019684-003 Sep 6, 1989 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.